EUVIMEDEUVIMED entdecken
Crossref

Inflammatory response to repeated subcutaneous esketamine in treatment-resistant depression: The role of baseline C-reactive protein

Patricia Cavalcanti-Ribeiro, Lara Carvalho Araújo Melo De Souza, Vagner Deuel O de Tavares, Raíssa Nóbrega de Almeida, Nicole Bezerra de Medeiros Lima, Kaike Thiê da Costa Gonçalves, Eduardo Igor Torquato Cardoso Lopes, Raynara Bolcont, Aldielyson Jorge Cavalcanti de Brito, Marcelo Falchi-Carvalho, Emerson Arcoverde, Draulio Barros de Araujo und 2 weitere

Journal of Affective Disorders · 2026

DOI: 10.1016/j.jad.2025.120877 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von Patricia Cavalcanti-Ribeiro und 13 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Onofre Lopes, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil; Psychobiology Postgraduate Program, …. Hauptthemen laut MEDLINE: C-Reactive Protein, Depressive Disorder, Treatment-Resistant, Ketamine, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Treatment-resistant depression (TRD) remains a major clinical challenge, with inflammation increasingly implicated in its pathophysiology. C-reactive protein (CRP), an accessible biomarker, has emerged as a potential predictor of antidepressant response. While intravenous and intranasal ketamine have shown anti-inflammatory effects, evidence linking inflammation and clinical outcomes remains inconsistent. The effects of subcutaneous (SC) esketamine on CRP and symptom improvement have not been explored. OBJECTIVE: To investigate whether baseline CRP predicts clinical response, whether SC esketamine reduces CRP in inflamed patients, and whether CRP changes are associated with symptom improvement. METHODS: This secondary analysis derived from an open-label trial included 22 TRD patients who received seven weekly SC esketamine doses. Patients were stratified by CRP (>1 mg/L = inflammation; ≤1 mg/L = non-inflammation). Depression severity was assessed with the Montgomery-Åsberg Depression Rating Scale (MADRS). RESULTS: The inflammation group (n = 8) showed significant CRP reductions (week 4: p = 0.005; week 8: p < 0.001); non-inflamed patients showed no significant change. By week 8 (which corresponded to the seventh application), both groups had comparable CRP levels (p = 0.170; 95 % CI [-2.923 to 0.258]). Age, sex, and BMI did not influence CRP changes. Although the inflammation group had greater depressive symptom reduction (ΔMADRS = 15.88 vs. 11.14), this was not statistically significant (p = 0.280). CRP changes did not predict to symptom improvement (p = 0.774). CONCLUSION: Exploratory findings suggest that patients with elevated baseline CRP showed within-group decreases over time, without clinical correlation. Larger controlled studies with broader immune profiling are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

C-Reactive ProteinDepressive Disorder, Treatment-ResistantKetamineInflammationAntidepressive AgentsMajor Depressive DisorderHumansMaleFemaleMiddle AgedAdultInjections, SubcutaneousTreatment OutcomeBiomarkers

Stichwörter der Autor:innen

Antidepressant responseC-reactive proteinEsketamineInflammationSubcutaneous administrationTreatment-resistant depression

Substanzen

C-Reactive ProteinKetamineEsketamineAntidepressive AgentsBiomarkers

Autor:innen und Institutionen

  • University Hospital Onofre Lopes, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil; Psychobiology Postgraduate Program, Department of Physiology and Behavior, Federal University of Rio Grand…
  • Brain Institute, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.
  • University Hospital Onofre Lopes, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil; Faculty of Nursing, University of Calgary, Calgary, AB, Canada.
  • Center for Advanced Psychedelic Medicine, Natal, RN, Brazil; Laboratory of Hormone Measurement, Department of Physiology and Behavior, Federal University of Rio Grande do Norte, Natal, RN, Brazil; Postgraduate Program i…
  • University Hospital Onofre Lopes, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.
  • Faculty of Nursing, University of Calgary, Calgary, AB, Canada.

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Cavalcanti-Ribeiro, P., De Souza, L. C. A. M., de Tavares, V. D. O., de Almeida, R. N., de Medeiros Lima, N. B., da Costa Gonçalves, K. T., Lopes, E. I. T. C., Bolcont, R., de Brito, A. J. C., Falchi-Carvalho, M., Arcoverde, E., de Araujo, D. B., Palhano-Fontes, F., & Galvão-Coelho, N. L. (2026). Inflammatory response to repeated subcutaneous esketamine in treatment-resistant depression: The role of baseline C-reactive protein. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.120877

Vancouver

Cavalcanti-Ribeiro P, De Souza LCAM, de Tavares VDO, de Almeida RN, de Medeiros Lima NB, da Costa Gonçalves KT, et al. Inflammatory response to repeated subcutaneous esketamine in treatment-resistant depression: The role of baseline C-reactive protein. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2025.120877

BibTeX
@article{CavalcantiRibeiro2026,
  author = {Cavalcanti-Ribeiro, Patricia and De Souza, Lara Carvalho Araújo Melo and de Tavares, Vagner Deuel O and de Almeida, Raíssa Nóbrega and de Medeiros Lima, Nicole Bezerra and da Costa Gonçalves, Kaike Thiê and Lopes, Eduardo Igor Torquato Cardoso and Bolcont, Raynara and de Brito, Aldielyson Jorge Cavalcanti and Falchi-Carvalho, Marcelo and Arcoverde, Emerson and de Araujo, Draulio Barros and Palhano-Fontes, Fernanda and Galvão-Coelho, Nicole Leite},
  title = {Inflammatory response to repeated subcutaneous esketamine in treatment-resistant depression: The role of baseline C-reactive protein},
  journal = {Journal of Affective Disorders},
  year = {2026},
  doi = {10.1016/j.jad.2025.120877}
}
Kostenlos starten →